These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 42416

  • 1. Dissolution, bioavailability and pharmacokinetics of three nitrofuratoin preparations in man.
    Bron J, Vree TB, Damsma JE, Hekster YA, van der Kleijn E.
    Arzneimittelforschung; 1979; 29(10):1614-20. PubMed ID: 42416
    [No Abstract] [Full Text] [Related]

  • 2. Pharmaceutical availability from oral dosage forms: in vitro release of nitrofurantoin from tablets and capsules.
    Senjković R, Kallay N, Vilendecić M.
    Pharmazie; 1987 Mar; 42(3):186-8. PubMed ID: 3602077
    [Abstract] [Full Text] [Related]

  • 3. Comparative pharmacokinetics and relative bioavailability for different preparations of nitrofurantoin.
    Maier-Lenz H, Ringwelski L, Windorfer A.
    Arzneimittelforschung; 1979 Mar; 29(12):1898-901. PubMed ID: 583541
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vivo/in vitro correlation regarding nitrofurantoin tablets.
    Munoz Carnago E, Gonzales Porto E.
    Pharmazie; 1986 Apr; 41(4):290-1. PubMed ID: 3725877
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Drug formulation and biologic availability.
    Poole JW.
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of formulation and process variables on bioequivalency of nitrofurantoin I: preliminary studies.
    Mendes RW, Masih SZ, Kanumuri RR.
    J Pharm Sci; 1978 Nov; 67(11):1613-6. PubMed ID: 712602
    [Abstract] [Full Text] [Related]

  • 15. The bioavailability of diazepam from uncoated tablets in humans--Part I: correlation with the dissolution rates of the tablets.
    Ogata H, Aoyagi N, Kaniwa N, Koibuchi M, Shibazaki T, Ejima A, Tsuji S, Kawazu Y.
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):159-65. PubMed ID: 7076345
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF.
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sustained-release dosage form of nitrofurantoin. Part 2. In vivo urinary excretion in man.
    Ertan G, Karasulu E, Abou-Nada M, Tosun M, Ozer A.
    J Microencapsul; 1994 Oct; 11(2):137-40. PubMed ID: 8006760
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.